Human Genome Project and cystic fibrosis--a symbiotic relationship.
When Watson and Crick determined the structure of DNA in 1953, a biological revolution began. One result of this revolution is the Human Genome Project. The primary goal of this international project is to obtain the complete nucleotide sequence of the human genome by the year 2005. Although molecular biologists and geneticists are most enthusiastic about the Human Genome Project, all areas of clinical medicine and fields of biology will be affected. Cystic fibrosis is the most common, inherited, lethal disease of white persons. In 1989, researchers located the cystic fibrosis gene on the long arm of chromosome 7 by a technique known as positional cloning. The most common mutation (a 3-base pair deletion) of the cystic fibrosis gene occurs in 70% of patients with cystic fibrosis. The knowledge gained from genetic research on cystic fibrosis will help researchers develop new therapies (e.g., gene) and improve standard therapies (e.g., pharmacologic) so that a patient's life span is increased and quality of life is improved. The purpose of this review is twofold. First, the article provides an overview of the Human Genome Project and its clinical significance in advancing interdisciplinary care for patients with cystic fibrosis. Second, the article includes a discussion of the genetic basis, pathophysiology, and management of cystic fibrosis.
Tolstoi
L G
LG
Department of Biomedical Engineering, Boston University, Mass., USA.
Smith
C L
CL
D002874:Chromosome Mapping; D003550:Cystic Fibrosis / Q000178:diet therapy / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D015316:Genetic Therapy; D016045:Human Genome Project; D006801:Humans; D007223:Infant; D010179:Pancreas / Q000201:enzymology; D016133:Polymerase Chain Reaction; D017422:Sequence Analysis, DNA
C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator